CVS analyst estimates
CVS Health (CVS) analyst ratings, the average price target and its range, and every firm's latest call.
- 17 firms rate CVS: 17 buy, 0 hold, 0 sell.
- The average price target is $110.56 from None analysts, from $103.00 to $123.00.
CVS analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 13, 2026 | Piper Sandler | CVS Health (CVS) PT Lowered to $106 at Bernstein SocGen Group | $106.00 |
| Nov 6, 2026 | Raymond James | CVS Health (CVS) PT Lowered to $103 at Raymond James | $103.00 |
| Nov 4, 2026 | Bank of America Securities | BofA Securities Reiterates Buy Rating on CVS Health (CVS) | $110.00 |
| Nov 4, 2026 | UBS | TD Cowen Reiterates Buy Rating on CVS Health (CVS) | $110.00 |
| Nov 4, 2026 | Raymond James | Raymond James Reiterates Outperform Rating on CVS Health (CVS) | $120.00 |
| Nov 4, 2026 | Jefferies | CVS Health (CVS) PT Lowered to $103 at Jefferies | $103.00 |
| Oct 12, 2026 | Leerink Partners | CVS Health price target lowered to $112 from $119 at Leerink | $112.00 |
| Sep 9, 2026 | BMO Capital | CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group | $112.00 |
| Sep 9, 2026 | Bernstein | CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group | $112.00 |
| Sep 9, 2026 | Piper Sandler | CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group | $112.00 |
| Sep 3, 2026 | UBS | CVS Health price target lowered to $118 from $126 at UBS | $118.00 |
| Aug 19, 2026 | Argus Research | CVS Health price target raised to $114 from $104 at Argus | $114.00 |
| Aug 6, 2026 | Barclays | CVS Health price target raised to $108 from $106 at Barclays | $108.00 |
| Aug 6, 2026 | UBS | CVS Health (CVS) PT Raised to $126 at UBS | $126.00 |
| Aug 6, 2026 | Robert W. Baird | CVS Health price target raised to $107 from $94 at Baird | $107.00 |